Free Trial

Teacher Retirement System of Texas Sells 132,911 Shares of Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health logo with Medical background

Teacher Retirement System of Texas lessened its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 49.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 138,277 shares of the company's stock after selling 132,911 shares during the period. Teacher Retirement System of Texas owned approximately 0.06% of Cardinal Health worth $19,050,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Pinnacle Bancorp Inc. grew its position in shares of Cardinal Health by 11.2% in the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock valued at $106,000 after purchasing an additional 77 shares during the last quarter. CSS LLC IL grew its holdings in Cardinal Health by 0.8% in the 4th quarter. CSS LLC IL now owns 11,190 shares of the company's stock valued at $1,323,000 after buying an additional 90 shares during the last quarter. Perigon Wealth Management LLC increased its position in Cardinal Health by 4.2% in the 1st quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company's stock worth $309,000 after buying an additional 90 shares during the period. Smith Shellnut Wilson LLC ADV lifted its holdings in shares of Cardinal Health by 2.1% during the first quarter. Smith Shellnut Wilson LLC ADV now owns 4,399 shares of the company's stock worth $606,000 after buying an additional 91 shares during the last quarter. Finally, TIAA Trust National Association boosted its position in shares of Cardinal Health by 4.5% in the fourth quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after acquiring an additional 94 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Trading Up 1.7%

Shares of Cardinal Health stock traded up $2.82 during mid-day trading on Friday, reaching $164.80. 1,234,057 shares of the stock were exchanged, compared to its average volume of 2,245,561. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $168.44. The company has a market cap of $39.33 billion, a price-to-earnings ratio of 25.71, a price-to-earnings-growth ratio of 1.63 and a beta of 0.68. The firm has a 50-day simple moving average of $155.58 and a 200 day simple moving average of $137.16.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The business's revenue was up .0% on a year-over-year basis. During the same period last year, the firm posted $2.08 EPS. On average, research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a $0.5107 dividend. The ex-dividend date is Tuesday, July 1st. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.24%. Cardinal Health's payout ratio is currently 31.83%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CAH. Citigroup reaffirmed a "neutral" rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Morgan Stanley set a $181.00 price objective on shares of Cardinal Health and gave the company an "overweight" rating in a research report on Friday, June 13th. Evercore ISI reissued an "outperform" rating and set a $180.00 target price (up from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Mizuho boosted their price target on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Finally, UBS Group raised their price objective on Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research report on Tuesday, April 29th. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and an average price target of $157.43.

View Our Latest Stock Analysis on CAH

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines